(Q44141707)

English

Poly(ADP-ribose) polymerase inhibitor increases growth inhibition and reduces G(2)/M cell accumulation induced by temozolomide in malignant glioma cells.

scientific article published in October 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12237842%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Poly(ADP-ribose) polymerase inhibitor increases growth inhibition and reduces G(2)/M cell accumulation induced by temozolomide in malignant glioma cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12237842%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

0 references

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12237842%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Grazia Graziani

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12237842%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Ilaria Portarena

2

object named as

Ilaria Portarena

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12237842%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

author name string

Francesco Torino

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12237842%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Massimo Scerrati

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12237842%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Pierluigi Navarra

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12237842%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

publication date

1 October 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12237842%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12237842%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

40

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12237842%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12237842%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

44-54

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12237842%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Analysis of microsatellite repeats in pediatric brain tumors.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

Potentiation of temozolomide-induced cytotoxicity: a comparative study of the biological effects of poly(ADP-ribose) polymerase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

Potentiation of anti-cancer agent cytotoxicity by the potent poly(ADP-ribose) polymerase inhibitors NU1025 and NU1064.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

Grading of astrocytomas. A simple and reproducible method.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

Clinical applications of telomerase in cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

Chemotherapy of brain tumors.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

Histopathology, classification, and grading of gliomas

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

Microsatellite instability and mutation of DNA mismatch repair genes in gliomas.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

Temozolomide for recurrent high-grade glioma

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

Health-related quality of life in patients with anaplastic astrocytoma during treatment with temozolomide.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

Chemotherapy in the treatment of recurrent glioblastoma multiforme: ifosfamide versus temozolomide

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

A survey of telomerase activity in human cancer

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

Low frequency of replication errors in primary nervous system tumours

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

Combined effects of adenovirus-mediated wild-type p53 transduction, temozolomide and poly (ADP-ribose) polymerase inhibitor in mismatch repair deficient and non-proliferating tumor cells.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

Effects of single or split exposure of leukemic cells to temozolomide, combined with poly(ADP-ribose) polymerase inhibitors on cell growth, chromosomal aberrations and base excision repair components.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

Poly (ADP-ribose) polymerase inhibitor increases apoptosis and reduces necrosis induced by a DNA minor groove binding methyl sulfonate ester

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

Combined treatment with temozolomide and poly(ADP-ribose) polymerase inhibitor enhances survival of mice bearing hematologic malignancy at the central nervous system site

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

Apoptotic and genotoxic effects of a methyl sulfonate ester that selectively generates N3-methyladenine and poly(ADP-ribose) polymerase inhibitors in normal peripheral blood lymphocytes.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

O (6)-Alkylguanine-DNA Alkyltransferase Assay

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

3-aminobenzamide and/or O6-benzylguanine evaluated as an adjuvant to temozolomide or BCNU treatment in cell lines of variable mismatch repair status and O6-alkylguanine-DNA alkyltransferase activity

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

Poly(ADP-ribose) polymerase-independent potentiation of nitrosourea cytotoxicity by 3-aminobenzamide in human malignant glioma cells.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

21 January 2018

Disturbances in DNA precursor metabolism associated with exposure to an inhibitor of poly(ADP-ribose) synthetase

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced detection of human telomerase activity

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with temozolomide and poly(ADP-ribose) polymerase inhibitors induces early apoptosis and increases base excision repair gene transcripts in leukemic cells resistant to triazene compounds

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10113

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/GLIA.10113

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12237842%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12237842%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44141707&oldid=2107060682"